DAVID KATZMAN: Open Payments
NPI 1346308392 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 17 payments from 6 companies in 2025. Trend: 2023 $382 · 2024 $203 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $243 |
| PFIZER INC. | 3 | $55 |
| Lilly USA, LLC | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Antares Pharma, Inc. | 1 | $17 |
Products named: QULIPTA, MOUNJARO, UBRELVY, NURTEC ODT, AIRSUPRA, VOQUEZNA, ELIQUIS, XYOSTED.
Industry payments across MO — which companies pay providers there.
